华润医药(03320.HK)旗下华润博雅生物单采血浆站 获达拉特旗市场监督管理局颁发营业执照

阿斯达克财经
26 Jun

华润医药(03320.HK) 宣布,旗下华润博雅生物下属单采血浆站“达拉特旗博雅单采血浆有限公司”取得达拉特旗市场监督管理局颁发的《营业执照》,获得原料血浆采集与供应的项目许可。
达拉特旗浆站将按照相关法律法规及标准要求进行建设,建成后根据《单采血浆站管理办法》等有关要求提交执业申请,经验收合格后开展采浆工作。
集团指,此次达拉特旗浆站获颁营业执照,是华润博雅生物夯实原料血浆战略基础的关键一步,将为集团整体经营产生带来积极影响。未来,华润医药将稳步拓展浆站资源,持续提升浆站服务质量。(sl/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-06-26 12:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10